Business Intelligence Center
You are here: Home : White Papers : Banking & Capital Markets : Alternative Finance : Abstract
Corporate Partnering as a Business Development Strategy for Middle Market Companies
Sponsored By Greenberg Traurig, LLP
Free registration is required
- Abstract:
- If electing to pursue a Corporate Partnering Transaction with SmallCo, a MidCo should be sure that its deal implementation team includes lawyers with expertise not only in the substantive area to which the contemplated Commercial Rights Agreement pertains, but also expertise in venture capital investing (and vice versa). While not all is perfect about the way VC's typically structure their Investment Agreements with Early Stage Companies, hundreds of VC's have made thousands of investments in Early Stage Companies over many years - there is, indeed, a wisdom to many of the concepts embodied in their form agreements. Accordingly, having legal counsel with a strong familiarity with standard VC oriented Investment Agreement documentation is a way for a MidCo to make sure the terms of its Investment Agreements with an Early Stage Company do not wind-up making it a "patsy".
- DETAILS
- Sponsored by: Greenberg Traurig, LLP
- Released: May 19, 2009
- Length: 15 pages
- Format: PDF (1044 kb)
- Email this abstract
- These white papers are not created by the CFO.com editorial staff. In order to view these papers, you must register with CFO.com and agree to share your contact information with related product/service companies.
Related White Papers in Mergers & Acquisitions
Related White Papers in Alternative Finance
- Asian Expert Networks
- How To Buy Credit Insurance
- An Innovation In Loan Covenant Management For Midmarket Companies
- Market Structure Is Causing The IPO Crisis
- Monetizing Accounts Receivable Into Cash: Financial executives and business owners know the value working capital provides to their companies
advertisement
Inside CFO.com
- Top Story
- CFOs Embrace Change and Spotlight
- Most Recent Mergers and Acquisitions Articles
- No Future Tax Shock for Bristol-Myers
- Deal Doldrums
- Ghosts of Barbarians Limit New NOL Rule


Video